Structure Therapeutics has the potential to have a best-in-class GLP-1 agonist drug for treatment of patients with obesity. Learn more on GPCR stock here.

Face, stomach, hips, legs. No, it’s not a new dance routine. Instead, it’s what might be going through your mind when trying ...

Terns Pharmaceuticals' (TERN) stock has risen somewhat due to some optimism around its early-stage clinical programs ...

Weighing over 35 stone left Eric Esch, better known as Butterbean, counting his days – but two years on he's now nearly half ...

Noom is rolling out two new solutions that aim to make it easier for employers and members to manage GLP-1s, and it's teaming ...

Dr. Ursula White, an associate professor of Clinical Science at Pennington Biomedical Research Center, is taking a deep dive into the lasting health effects of short-term weight gain and weight loss.

Drugs such as Ozempic have transformed weight loss as we know it, but have we fully grasped yet the impact these drugs are ...

For 14 years, Jesse’s mind spiraled. So did his weight. The medications he took for schizophrenia drove his weight up until ...

The personalised diet allows people to easily increase the intake of two key nutrients while reducing calories - losing fat ...

ROME — Rome Health will offer a free weight loss seminar at 5:30 p.m. on Wednesday, Oct. 30, in the second floor classroom on ...

This research reinforces the health benefits of brief, energetic movements, known as 'exercise snacks' - which involve short ...